The Effect of Cold Exposure on Glucose Tolerance
1 other identifier
interventional
16
1 country
1
Brief Summary
The purpose of the study is to evaluate the effect of cold exposure on an individual's glucose tolerance. Previous research has already shown that 10 days acclimation to a mild cold environment (14-15°C) can enhance insulin sensitivity. However, the duration in the cold environment was 6 hours per day which may not be practical for everyone. Therefore, the present study will investigate the effect of a shorter, and more intense cold exposure on an individual's glucose tolerance. It is hypothesised that cold exposure before consuming a glucose drink will enhance glucose clearance.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jan 2019
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 11, 2018
CompletedFirst Posted
Study publicly available on registry
October 9, 2018
CompletedStudy Start
First participant enrolled
January 11, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2019
CompletedJuly 14, 2020
July 1, 2020
10 months
September 11, 2018
July 13, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Glucose and insulin concentrations in response to an oral glucose load
3 hours post glucose drink, measured 90 minutes after the cold exposure
Secondary Outcomes (9)
Energy expenditure measured using indirect calorimetry
30 minutes before and during the 1 hour of cold exposure
Core temperature measured using a telemetric pill
30 minutes before and during the 1 hour of cold exposure
Skin blood flow measured using laser doppler flowmetry
30 minutes before and during the 1 hour of cold exposure
Shivering activity assessed using surface electromyography
30 minutes before and during the 1 hour of cold exposure
Systolic and diastolic blood pressure measured using an automatic blood pressure device
30 minutes before and during the 1 hour of cold exposure
- +4 more secondary outcomes
Study Arms (2)
Cold exposure
EXPERIMENTALParticipants will be wrapped in a water-perfused suit. The temperature of the suit will be lowered to 10°C. From the onset of shivering, the participants will remain in the suit for 1 hour.
Thermoneutral (Control)
OTHERParticipants will be wrapped in a water-perfused suit. The temperature of the suit will remain at a thermoneutral temperature (32°C) to avoid shivering and excessive sweating. The duration will be matched to that during the cold exposure.
Interventions
Eligibility Criteria
You may qualify if:
- Signed informed consent.
- White European.
- Male.
- Age 18 - 40 years at the start of the study.
- BMI ≥ 20 and \< 30 kg/m2.
You may not qualify if:
- Smoking.
- Active diseases (cardiovascular, diabetes mellitus, liver, kidney, cancer or other).
- Cold-acclimated (takes daily cold baths, works in a refrigerated environment, or regular cold water swimmer).
- Unstable body weight (gain or loss \> 5kg in last 3 months).
- Currently undertaking a diet.
- Signed informed consent.
- White European.
- Male or female.
- Women should be postmenopausal or use hormonal contraceptives.
- Age 30 - 75 years at the start of the study.
- BMI ≥ 25 and \< 35 kg/m2.
- Generally healthy, no medication use that interferes with metabolism. If volunteers need medication (e.g. statin drugs, NSAIDs), it will be reviewed with the dependent physician on an individual basis.
- Impaired fasting glucose (5.6 mM to 6.9 mM) and/or blood glucose values 7.8-11.0 mM 2h after glucose drink consumption during OGTT in screening.
- Smoking.
- Active diseases (cardiovascular, diabetes mellitus, liver, kidney, cancer or other).
- +3 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Maastricht University
Maastricht, 6229 ER, Netherlands
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Wouter van Marken Lichtenbelt, PhD
Maastricht University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 11, 2018
First Posted
October 9, 2018
Study Start
January 11, 2019
Primary Completion
November 1, 2019
Study Completion
November 1, 2019
Last Updated
July 14, 2020
Record last verified: 2020-07